s6y

Akoya Biosciences, Inc.

CIK
1711933
Industry
Laboratory Analytical Instruments

Financials 18

  1. 10-Q Quarterly Report for period ending Mar 31, 2025
  2. 10-K/A Annual Report for period ending Dec 31, 2024
  3. 10-K Annual Report for period ending Dec 31, 2024
  4. 10-Q Quarterly Report for period ending Sep 30, 2024
  5. 10-Q Quarterly Report for period ending Jun 30, 2024
  6. 10-Q Quarterly Report for period ending Mar 31, 2024
  7. 10-K Annual Report for period ending Dec 31, 2023
  8. 10-Q Quarterly Report for period ending Sep 30, 2023
  9. 10-Q Quarterly Report for period ending Jun 30, 2023
  10. 10-Q Quarterly Report for period ending Mar 31, 2023

All 18 financials filings

News 47

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 47 news filings

Ownership 153

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 153 ownership filings

Prospectus 41

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. S-8 POS Post-effective amendment to a S-8 registration statement
  5. S-8 POS Post-effective amendment to a S-8 registration statement
  6. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  7. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  8. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  9. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
  10. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

All 41 prospectus filings

Proxies 8

  1. DEFM14A Definitive proxy statement relating to a merger, acquisition, or disposition
  2. DEFM14A Definitive proxy statement relating to a merger, acquisition, or disposition
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. DEF 14A Definitive proxy statements
  5. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  6. DEF 14A Definitive proxy statements
  7. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  8. DEF 14A Definitive proxy statements

Other 43

  1. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  2. EFFECT Notice of Effectiveness
  3. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  4. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  5. SCHEDULE 13D/A
  6. SCHEDULE 13D/A
  7. SCHEDULE 13D
  8. SCHEDULE 13D
  9. 144 Filing for proposed sale of securities under Rule 144
  10. 144 Filing for proposed sale of securities under Rule 144

All 43 other filings